# MIROFEND LLC: A NEW TREATMENT APPROACH FOR LETHAL DRUG-RESISTANT BACTERIAL SKIN INFECTIONS

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | MIROFEND LLC |
| Location | DALLAS, TX |
| Project | A NEW TREATMENT APPROACH FOR LETHAL DRUG-RESISTANT BACTERIAL SKIN INFECTIONS |
| Project number | 1R41AI197653-01 |
| Mechanism | R41 |
| Institute | National Institute of Allergy and Infectious Diseases |
| Award | $303,933 |
| Awarded | 2026-09-09 |
| Project period | 2026-09-09 to 2027-08-31 |
| UEI | J4RDBKNNAZH9 |

## Why this score
- Award of $303,933.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11314321). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.